| 1 | DMD, SSPN, UTRN
|
| Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.
|
| Marshall JL, Chou E, Oh J, Kwok A, Burkin DJ, Crosbie-Watson RH.
|
| Hum Mol Genet 21(20):4378-93. Epub 2012 Jul 13.
2012
|
| 2 | AKT1, SSPN, UTRN
|
| Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.
|
| Marshall JL, Holmberg J, Chou E, Ocampo AC, Oh J, Lee J, Peter AK, Martin PT, Crosbie-Watson RH.
|
| J Cell Biol 197(7):1009-27. doi: 10.1083/jcb.201110032.
2012
|
| 3 | SSPN
|
| Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.
|
| Marshall JL, Holmberg J, Chou E, Ocampo AC, Oh J, Lee J, Peter AK, Martin PT, Crosbie-Watson RH.
|
| J Cell Biol 197(7):1009-27. doi: 10.1083/jcb.201110032.
2012
|
| 4 | CYC1, SSPN, SUPT6H
|
| Spn1 regulates the recruitment of Spt6 and the Swi/Snf complex during transcriptional activation by RNA polymerase II.
|
| Zhang L, Fletcher AG, Cheung V, Winston F, Stargell LA.
|
| Mol Cell Biol 28(4):1393-403. Epub 2007 Dec 17.PMID: 18086892 2008
|
| 5 | SSPN, UTRN
|
| Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex.
|
| Peter AK, Marshall JL, Crosbie RH.
|
| J Cell Biol 183(3):419-27. doi: 10.1083/jcb.200808027.
2008
|
| 6 | SSPN
|
| Reduced expression of sarcospan in muscles of Fukuyama congenital muscular dystrophy.
|
| Wakayama Y, Inoue M, Kojima H, Yamashita S, Shibuya S, Jimi T, Hara H, Matsuzaki Y, Oniki H, Kanagawa M, Kobayashi K, Toda T.
|
| Histol Histopathol 23(12):1425-38.
2008
|
| 7 | SSPN
|
| Gene expression in mouse brain following chronic hypoxia: role of sarcospan in glial cell death.
|
| Zhou D, Wang J, Zapala MA, Xue J, Schork NJ, Haddad GG.
|
| Physiol Genomics 32(3):370-9. Epub 2007 Dec 4.
2008
|
| 8 | SSPN
|
| Analysis of human sarcospan as a candidate gene for CFEOM1.
|
| O'Brien KF, Engle EC, Kunkel LM.
|
| BMC Genet 2:3. Epub 2001 Feb 6.
2001
|
| 9 | SSPN
|
| Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.
|
| Crosbie RH, Lim LE, Moore SA, Hirano M, Hays AP, Maybaum SW, Collin H, Dovico SA, Stolle CA, Fardeau M, Tome FM, Campbell KP.
|
| Hum Mol Genet 9(13):2019-27. 2000
|
| 10 | SGCA, SGCD, SSPN
|
| Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.
|
| Coral-Vazquez R, et al.
|
| Cell 98(4):465-74. 1999
|
| 11 | SSPN
|
| Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex.
|
| Crosbie RH, Heighway J, Venzke DP, Lee JC, Campbell KP.
|
| J Biol Chem 272(50):31221-4. 1997
|
| 12 | ITPR2, SSPN, KRAS
|
| Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
|
| Heighway J, et al.
|
| Genomics 35 : 207-214. 1996
|